BBS’s Primary growth strategy is to connect with the export markets. As a leader in the market of medicinal cannabis, BBS is focusing on establishing regional […]
BBS Pharmaceuticals CEO, John Dagas has been elected on the Hellenic Biocluster Board. Based in Athens, Hellenic Biocluster the first biosciences cluster in Greece bringing together […]
If Australia’s aspiration to become the world’s largest exporter of medicinal cannabis is to be realised, then a further review of the licence regime is required. […]
Thousands of Australians are now using medicinal cannabis to treat conditions like chronic pain and anorexia. Last February, the ABC revealed more than 3,100 medicinal cannabis […]
Cannabidiol-enriched cannabis use in pediatric treatment helps with mental health and treatment-resistant epilepsy. Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays, and impaired quality […]
BBS Pharmaceuticals has been recognised as a key player in the global cannabis market according to a recent report published by Oriana Research. Cannabis Capsule Market […]
Cannabis has been used for medicinal purposes for centuries, but despite the therapeutic benefits of the plant, international regulators ultimately deemed it unsafe for the public […]
According to New Frontier Data, the legalization of cannabis may prove to be one of the most consequential social changes of our time, and governments, investors, […]